| Aurobindo gets USFDA nod for hypertension drug | 12-NOV-09 |
|
| Hyderabad-based Aurobindo Pharma announced that it had received final approval from the US Food and Drug Administration (USFDA) for Perindopril Erbumine tablets meant for treatment of hypertension. |
|
|
|
|
|
|
| Aurobindo Pharma gets USFDA approval | 06-NOV-09 |
|
| Hyderabad-based, Aurobindo Pharma has received the approval for its chewable and dispersible Lamotrigine tablets from the US Food & Drug Administration (USFDA). |
|
|
|
| Aurobindo back in black with Rs 103 cr profit | 30-OCT-09 |
|
| Aurobindo Pharma, Hyderabad-based manufacturer of generic and active pharmaceutical ingredients reported a net profit of Rs 103.2 crore for the quarter ended September 30, 2009, as against a net loss of Rs 38.4 crore during the corresponding period last year. Revenues were up 24.42 per cent to Rs 882.64 crore as compared with Rs 709.4 crore last year. |
|
|
|
| Aurobindo gets nod to market 2 more products in S Africa | 29-OCT-09 |
|
| Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received approval from the Medicines Control Council (MMC) to manufacture and market two more products in South Africa. |
|
|
|
|
|
|
| Aurobindo gets US FDA nod | 19-SEP-09 |
|
| Aurobindo Pharma Limited has received the tentative approval for Atomoxetine Hydrochloride capsules in 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg strengths. |
|
|
|
| Aurobindo Pharma receives Swissmedic approval | 07-SEP-09 |
|
| Aurobindo Pharma Limited announced that it received two approvals from Swissmedic, a Switzerland government agency for therapeutic products, for the licence of Amlodipine APL 5mg and 10 mg tablets and Melformin APL 500 mg, 850 mg and 1,000 mg tablets. |
|
|
|
|
|
|
| Aurobindo Pharma up 2.4% | 18-AUG-09 |
|
| The share price of Aurobindo Pharma moved up 2.39 per cent intra day on the announcement that the company would acquire 100 per cent stake of Trident Life Sciences. |
|
|
|
| Aurobindo to acquire Trident Life | 18-AUG-09 |
|
| Aurobindo Pharma Ltd, a manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), is planning to acquire the entire stake in Trident Life Sciences Ltd (TLSL), a city-based clinical research organisation (CRO). |
|
|
|
|
|
|
|
|
|
| Aurobindo gets FDA nod for muscle relaxant | 07-AUG-09 |
|
| Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received the final approval for carisoprodol tablets USP in 350mg strength from the US Food and Drug Administration (US FDA), taking its total number of abbreviated new drug application (ANDA) approvals from the US drug regulator to 100.
Carisoprodol tablets USP 350mg, the generic equivalent to Soma Tablets of Meda Pharmaceuticals, are muscle relaxants and are |
|
|
|
| Aurobindo Pharma hits 52-week high | 03-AUG-09 |
|
| The stock extended gains and soared to a high of Rs 624 - up nearly 8% from its low. Finally it ended with a gain of 7% at Rs 631. Around 811,98 shares changed hands at the BSE today. |
|
|
|
Content Guide
